Search results
Antibodies may aid effort to fight influenza B
Science Daily· 7 days agoSeasonal flu vaccines cover influenza B and the more common influenza A but do not stimulate the broadest possible range of immune responses against both viruses. In addition ...
Theralase(R) Technology Effective in Virus Inactivation
The Joplin Globe· 3 days agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
This Personality Change Could Actually Be a Sign of Infection, According to Doctors
Parade· 2 days ago"Understanding early symptoms of potential infection increases the ability for earlier intervention...
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type...
Morningstar· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target action date of its priority review ...
New U.S. Rules for Dangerous Pathogen Research, Explained
The Dispatch via Yahoo News· 4 days agoHe would like to see a transformation in infectious disease research and development that uses the...
Bird flu update: 3rd human case diagnosed. Penn vaccine testing set. What about raw milk?
The Express-Times· 5 days agoRussell Redding had a cone of premise-made ice cream in hand, a reward after having just kicked off...
Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount
InvestorPlace· 5 days agoWhile macro-related issues are a factor, it’s company-specific issues that play a more significant...
Opinion | Psychiatry and the Dangerous Patient
New York Times· 2 days agoThe article mentions that staff members are assaulted, and on inpatient units, patients are also sometimes assaulted by other patients. The article...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoThe European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union (EU) ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoThe US Food and Drug Administration (FDA) has extended by three months the target action date of its priority review of the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab ...
